Home › NDC Lookup › RxCUI directory › RxCUI 994541

2 ML orphenadrine citrate 30 MG/ML Injection — RxCUI 994541

RxNorm drug concept · Semantic clinical drug
RxCUI 994541 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI994541
Official name2 ML orphenadrine citrate 30 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asorphenadrine citrate 60 MG per 2 ML Injection; orphenadrine citrate 60 MG in 2 ML Injection
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)13,767 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Orphenadrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a common assumption, but orphenadrine actually doesn't directly relax tense muscles. Researchers believe its benefit comes from pain-relieving properties — so it helps you fee...
  • What exactly does orphenadrine do — does it just relax my muscles?
  • Take one extended-release tablet in the morning and one in the evening — that's twice a day. Try to stick to the same times each day. If you're unsure whether to take it with food...
  • How should I take the extended-release tablet?
📖 Read our full Orphenadrine guide →

🕸️ Concept Web — How 2 ML orphenadrine citrate 30 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML orphenadrine citrate 30 MG/ML Injection RxCUI 994541

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Orphenadrine 7715
    • Orphenadrine citrate 7716
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Orphenadrine Injection 1740450
    • Orphenadrine citrate Injection 2645986
    • Orphenadrine Injectable Product 1161642
    • Orphenadrine citrate Injectable Product 2662838
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Orphenadrine citrate 30 MG/ML 994540

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Orphenadrine citrate 30 MG/ML SCDC · 994540
  • Orphenadrine Injection SCDF · 1740450
  • Orphenadrine citrate Injection SCDFP · 2645986
  • Orphenadrine Injectable Product SCDG · 1161642
  • Orphenadrine citrate Injectable Product SCDGP · 2662838

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 994541 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00591-3222-47 10 AMPULE in 1 CARTON (0591-3222-47) / 2 mL in 1 AMPULE (05... Orphenadrine Citrate Actavis Pharma, Inc. 2010-07-08
00641-6182-25 25 BOX in 1 BOX (0641-6182-25) / 10 VIAL in 1 BOX (0641-618... Orphenadrine citrate Hikma Pharmaceuticals USA Inc. 2003-04-28
25021-0651-02 10 VIAL in 1 CARTON (25021-651-02) / 2 mL in 1 VIAL Orphenadrine Citrate Sagent Pharmaceuticals 2011-10-01
Observed labelers: Actavis Pharma, Inc. (1) · Hikma Pharmaceuticals USA Inc. (1) · Sagent Pharmaceuticals (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2360 Orphenadrine injection 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.